Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Grows Stronger with Patents and Third-Party Partners
Improving the quality, taste and effectiveness of cannabis products with DehydraTECH Recently granted two new U.S. patents, with over 50 additional patent applications filed worldwide Applications span a wide range of products as the company out-licenses IP to third-party partners through a royalty model Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is using its DehydraTECH to increase the quality, taste and effectiveness of cannabis products. Lexaria’s revolutionary drug delivery platform is disrupting the way cannabidiol enters the bloodstream. Rather than relying on the traditional methods of inhalation, which has harmful lasting impact on a person’s health, DehydraTECH allows for a…